Does high estradiol on TRT actually matter if you feel fine?

What did @alphaclubsupps actually say?

The creator's core argument is that estradiol (E2) numbers don't matter much as long as you feel good. He says he personally keeps his E2 "way up in the high 300s" and feels better there than when it's in the normal lab range. He also argues that low E2 is actually the bigger clinical concern, and that symptoms, not numbers, should drive TRT management decisions.

To his credit, he at least lists real symptoms to watch for: mood swings, erectile dysfunction, water retention, and elevated blood pressure. He's not telling people to ignore symptoms entirely. But his framing, that a level nearly ten times the upper end of typical male lab ranges is personally optimal and apparently unremarkable, is where things start to fall apart.

He also mentions running EQ (Equipoise, an anabolic steroid) as the reason his E2 dropped. That context matters a lot and gets almost no airtime in this video.

Does the science back this up?

Partially, but not in the way he's presenting it. The "how you feel" principle has genuine clinical support in TRT literature, but that support applies within a reasonable physiological range, not at E2 levels of 300+ pg/mL.

Finkelstein et al. (2013, NEJM) showed that estradiol plays a significant role in male sexual function and that low E2 does meaningfully impair libido and erectile function. That part of his argument is solid. The study found that men with low testosterone AND low estradiol had worse sexual symptoms than those with low testosterone alone, supporting his point that tanking E2 feels terrible.

But the same physiology that makes estradiol important in normal ranges becomes a liability at supraphysiologic levels. Elevated E2 in men is associated with increased cardiovascular risk, specifically venous thromboembolism and adverse lipid changes. Canonico et al. and work by Loo et al. (2022, Journal of Clinical Endocrinology and Metabolism) have documented cardiovascular signal at elevated estrogen levels. There is no published evidence that E2 in the high 300s is safe long-term for men on TRT.

What did they get wrong (or right)?

He got one thing genuinely right: treating lab ranges as absolute cutoffs is bad medicine. Standard male reference ranges for estradiol (typically 10 to 40 pg/mL on older assays, or up to roughly 42 pg/mL on LC-MS/MS) were mostly derived from populations not on TRT. Men on testosterone replacement often run higher E2 naturally, and symptom-driven management has real clinical backing. Morgentaler and Traish (2015, Mayo Clinic Proceedings) have argued against reflexive AI use based on numbers alone.

But "don't panic at slightly elevated E2" is very different from "I keep mine in the high 300s and you should relax about yours." The creator is conflating two completely different scenarios. He's also actively using Equipoise, a veterinary-grade anabolic steroid that itself alters aromatization and carries serious cardiovascular risks. Presenting his personal hormone levels as a template for someone starting TRT is genuinely irresponsible. His "in range" feeling at 54 pg/mL versus 300+ pg/mL is a comparison between two very different drug protocols, not a lesson about lab ranges.

What should you actually know?

If you're on a standard TRT protocol (testosterone cypionate or enanthate at physiologic replacement doses), your E2 will likely run somewhat higher than untreated men. That's expected and usually not a problem if you feel well and your cardiovascular markers are stable. Most TRT-experienced clinicians use symptoms plus labs together, not one or the other.

The red flags worth taking seriously are persistent water retention, new or worsening hypertension, gynecomastia that's progressing, and significant mood instability. Those warrant a conversation with your prescriber, not a TikTok comment section.

What is not a useful data point for you: one person's self-reported feeling at E2 levels achieved through anabolic steroid use. The cardiovascular risks of chronically supraphysiologic estrogen in men are not well characterized because running E2 at 300+ pg/mL is not a studied therapeutic scenario. It's not a reference range. It's not a benchmark. It's one person's anecdote from a context that almost certainly doesn't apply to you.

• Low E2 on TRT is a real and underappreciated problem. That part he got right.
• Symptom-informed management is supported by evidence, within reason.
• E2 at 300+ pg/mL is not a validated or studied target for men on TRT.
• His numbers come from a polypharmacy context involving Equipoise, not standard TRT.